BR0012380A - 2-amino-benzoxazinones for the treatment of herpes simplex virus - Google Patents

2-amino-benzoxazinones for the treatment of herpes simplex virus

Info

Publication number
BR0012380A
BR0012380A BR0012380-3A BR0012380A BR0012380A BR 0012380 A BR0012380 A BR 0012380A BR 0012380 A BR0012380 A BR 0012380A BR 0012380 A BR0012380 A BR 0012380A
Authority
BR
Brazil
Prior art keywords
benzoxazinones
amino
treatment
herpes simplex
simplex virus
Prior art date
Application number
BR0012380-3A
Other languages
Portuguese (pt)
Inventor
Masashi Kawanishi
Wataru Takahashi
Original Assignee
Searle & Co
Asahi Kasei Kogyo Kabahiki Kai
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co, Asahi Kasei Kogyo Kabahiki Kai filed Critical Searle & Co
Publication of BR0012380A publication Critical patent/BR0012380A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/241,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"2- AMINO - BENZOXAZINONAS PARA O TRATAMENTO DE VìRUS DO HERPES SIMPLES". Agentes antivirais e métodos para tratar Vírus do Herpes Simples."2- AMINO - BENZOXAZINONES FOR THE TREATMENT OF HERPES SIMPLE VIRUS". Antiviral agents and methods for treating Herpes Simplex Virus.

BR0012380-3A 1999-07-12 2000-07-11 2-amino-benzoxazinones for the treatment of herpes simplex virus BR0012380A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14295699P 1999-07-12 1999-07-12
PCT/US2000/018817 WO2001003697A1 (en) 1999-07-12 2000-07-11 2-amino-benzoxazinones for the treatment of herpes simplex virus

Publications (1)

Publication Number Publication Date
BR0012380A true BR0012380A (en) 2002-08-27

Family

ID=22501956

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0012380-3A BR0012380A (en) 1999-07-12 2000-07-11 2-amino-benzoxazinones for the treatment of herpes simplex virus

Country Status (11)

Country Link
EP (1) EP1210088A4 (en)
JP (1) JP2003504334A (en)
KR (1) KR20020046273A (en)
CN (1) CN1481245A (en)
AU (2) AU774370B2 (en)
BR (1) BR0012380A (en)
CA (1) CA2378014A1 (en)
HK (1) HK1046862A1 (en)
MX (1) MXPA02000485A (en)
WO (1) WO2001003697A1 (en)
ZA (1) ZA200200311B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2066662E (en) * 2006-09-21 2013-02-13 Kyorin Seiyaku Kk Serine hydrolase inhibitors
EP4144336A1 (en) * 2021-05-14 2023-03-08 The Procter & Gamble Company Wet wipes with a cellulosic substrate and gentle lotion

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985872A (en) * 1995-05-24 1999-11-16 G.D. Searle & Co. 2-amino-benzoxazinones for the treatment of viral infections

Also Published As

Publication number Publication date
EP1210088A1 (en) 2002-06-05
CA2378014A1 (en) 2001-01-18
WO2001003697A1 (en) 2001-01-18
AU2004203884A1 (en) 2004-09-09
CN1481245A (en) 2004-03-10
AU774370B2 (en) 2004-06-24
KR20020046273A (en) 2002-06-20
MXPA02000485A (en) 2004-09-10
AU6208900A (en) 2001-01-30
EP1210088A4 (en) 2003-03-12
JP2003504334A (en) 2003-02-04
ZA200200311B (en) 2003-01-14
HK1046862A1 (en) 2003-01-30

Similar Documents

Publication Publication Date Title
NO985200L (en) Antimicrobial treatment for herpes simplex virus, and other infectious diseases
DK1143967T3 (en) Anticonvulsant derivatives suitable for the treatment of Horton's headache
IL129352A0 (en) Benzimidazole-2- carbamates for the treatment of viral infections and cancer
EP1109580A4 (en) Methods for treating or preventing viral infections and associated diseases
EP1115286A4 (en) Methods for treating or preventing viral infections and associated diseases
PT755249E (en) USE OF MAILLARD REACTION INHIBITORS FOR AMILOIDOSE-BASED DISEASE TREATMENT
BRPI0411900A (en) antiviral compounds and methods
TR199701212T1 (en) Use of alpha IL-agonists for the treatment of urinary incontinence.
DK0973735T3 (en) Polyaromatic antiviral preparations
FR2759581B1 (en) TREATMENT DEVICE, IN PARTICULAR WITH MOXA, OF THE ACUPRESSURE TYPE
TR200002965T2 (en) The use of organophosphorus preparations for the therapeutic and prophylactic treatment of infections
MY138883A (en) Use of asiatic acid for treatment of cencer
ATE402713T1 (en) GENETICALLY MANIPULATED HERPES VIRUSES FOR THE TREATMENT OF TUMORS
GB9709360D0 (en) Methods for the treatment of herpes virus infections
DK1242119T3 (en) Combinations for the treatment of DNA viral infections comprising a loop diuretic and a cardiac glycoside
ZA973622B (en) Use of forms of hyaluronic acid (HA) for the treatment of cancer.
BR9006664A (en) PROCESS FOR THE PREPARATION OF INSOLUBLE TANINE, PROCESS FOR THE TREATMENT OF WASTE USING INSOLUBLE TANINO, AND ADSORCATION PROCESS THAT USES TANINO
FI935780A (en) HIV protease inhibitors useful in the treatment of AIDS
BR9807227B1 (en) herbicidal composition for foliar treatment, process of elimination and use of said herbicidal composition.
BR0012380A (en) 2-amino-benzoxazinones for the treatment of herpes simplex virus
DK1133296T3 (en) New therapeutic use of nicergoline
PT799039E (en) USING AMINOPURIN ANIVIRAL AGENTS FOR THE TREATMENT AND PROPHYLAXIA OF LATENT INFECTIONS BY HERPES VIRUS
NO20005548D0 (en) Mykobakterieinhibitorer
DE69806062D1 (en) COMBINATION THERAPY FOR TREATING AIDS
DE69737088D1 (en) THERAPEUTIC AGENT FOR THE TREATMENT OF FIV INFECTIONS

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 8A E 9A ANUIDADES

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2008 DE 30/06/2009.